Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3Lymphoid 2Genitourinary 2Breast 2Thoracic 1Sarcoma 1Other solid neoplasm 1Myeloid 1Gynecologic 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Glioblastoma 11Brain Neoplasms 11Gliosarcoma 9Neuroblastoma 5Astrocytoma 5Oligodendroglioma 4Glioma 4Carcinoma, Renal Cell 4Sarcoma, Ewing 3Sarcoma 3Rhabdomyosarcoma 3Rhabdoid Tumor 3Recurrence 3Neoplasms, Germ Cell and Embryonal 3Central Nervous System Neoplasms 3Breast Neoplasms 3Wilms Tumor 2Prostatic Neoplasms 2Osteosarcoma 2Neurofibromatosis 2 2Neurofibromatosis 1 2Neoplasms 2Melanoma 2Medulloblastoma 2Ependymoma 2Carcinoma, Hepatocellular 2Vestibulocochlear Nerve Diseases 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 6Specimen Handling 3Nivolumab 3Fluorodeoxyglucose F18 3Cisplatin 3Cetuximab 3ulixertinib 2tipifarnib 2selpercatinib 2binimetinib 2Trastuzumab 2Surveys and Questionnaires 2Radiotherapy 2Paclitaxel 2Immunoglobulin G 2Gemcitabine 2FAPI-46 2Disulfides 2Biopsy 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1trastuzumab biosimilar HLX02 1trametinib 1temsirolimus 1sargramostim 1sapanisertib 1romidepsin 1relatlimab 1pertuzumab 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × Sirolimus × CNS × Clear all
NCT01552434 2026-05-15

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

M.D. Anderson Cancer Center

Phase 1 Terminated
154 enrolled
BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡